Heylings J R, Diot S, Esdaile D J, Fasano W J, Manning L A, Owen H M
Syngenta Central Toxicology Laboratory, Alderley Park, Macclesfield, Cheshire SK10 4TJ, UK.
Toxicol In Vitro. 2003 Apr;17(2):123-38. doi: 10.1016/s0887-2333(02)00130-3.
A prevalidation study sponsored by the European Centre for the Validation of Alternative Methods (ECVAM) on in vitro tests for acute skin irritation is aimed at identifying non-animal tests capable of discriminating irritants (I) from non-irritants (NI), as defined according to European Union and OECD. This paper reports on Phase III for one of the methods, the skin integrity function test (SIFT), assessing the protocol performance of the SIFT, in terms of reproducibility and predictive ability, in three laboratories. The barrier function properties of excised mouse skin were determined using a set of 20 coded chemicals (10 I, 10 NI), using the endpoints of trans-epidermal water loss (TEWL) and electrical resistance (ER). The basis of the SIFT prediction model is if the ratios of the pre- and post-application values for either TEWL or ER are greater than five-fold, then the test chemical is deemed irritant (I). If the ratio of both parameters is less than five-fold then the chemical is deemed non-irritant (NI). Analysis of variance (ANOVA) indicated that the intra-lab reproducibility was acceptable but that the inter-lab reproducibility was not. Overall, the SIFT test under-predicted the irritancy of the test chemicals chosen for Phase III with an overall accuracy of only 55%. The sensitivity value (ability to correctly predict I) was only 30%. The specificity (ability to predict NI) of the test was better at 80%. A retrospective examination of the SIFT results was undertaken using Student's t-test and a significance level of P<0.05 to predict an irritant based on changes in the TEWL ratio values. This improved the predictivity of the SIFT test, giving a specificity of 60%, a sensitivity of 80% and an overall accuracy of 70%. Appropriate modifications to the prediction model have now been made and the SIFT will be re-examined in a new validation exercise to investigate the potential of this non-animal method to predict acute skin irritation potential.
由欧洲替代方法验证中心(ECVAM)发起的一项关于急性皮肤刺激性体外试验的预验证研究,旨在识别能够根据欧盟和经合组织的定义区分刺激物(I)和非刺激物(NI)的非动物试验。本文报告了其中一种方法——皮肤完整性功能试验(SIFT)的第三阶段,评估了该试验在三个实验室中的可重复性和预测能力方面的方案性能。使用一组20种编码化学品(10种刺激物,10种非刺激物),以经皮水分流失(TEWL)和电阻(ER)为终点,测定切除的小鼠皮肤的屏障功能特性。SIFT预测模型的基础是,如果TEWL或ER的应用前和应用后值的比率大于五倍,则测试化学品被视为刺激物(I)。如果两个参数的比率均小于五倍,则该化学品被视为非刺激物(NI)。方差分析(ANOVA)表明,实验室内的可重复性是可以接受的,但实验室间的可重复性则不然。总体而言,SIFT试验对第三阶段所选测试化学品的刺激性预测不足,总体准确率仅为55%。敏感性值(正确预测刺激物的能力)仅为30%。该试验的特异性(预测非刺激物的能力)较好,为80%。使用学生t检验和P<0.05的显著性水平对SIFT结果进行回顾性检查,以根据TEWL比率值的变化预测刺激物。这提高了SIFT试验的预测能力,特异性为60%,敏感性为80%,总体准确率为70%。现已对预测模型进行了适当修改,SIFT将在一项新的验证试验中重新进行检查,以研究这种非动物方法预测急性皮肤刺激潜力的可能性。